DAVE;
DAVE;
DAVE;
DAVE;
DAVE;
DAVE;
DAVE;
DAVE;
DAVE;
DAVE;
DAVE;
DAVE;
DAVE;
DAVE;
DAVE;

DAVE™ demo

DAVE™ links effectively with existing clinical record systems enabling the data to be read from, and recorded back into, the core GP system. The following example screen displays will guide you through some of the key software features.

Patient overview screen

DAVE™ care item toolbar

If the selected patient has diabetes, then a toolbar will be displayed showing the latest information recorded, indicating in red whether the patient is achieving the target recommended in the latest evidence or whether they are due for another check.

Click image to enlarge

DAVE™ clinical details

Click on any care item to see more patient information together with the relevant guideline recommendations. Patient data will be displayed both graphically and in detail and relevant treatments will be shown, alongside key information and guidance from the clinical recommendations.

Click image to enlarge

Glycaemic control screen
Diabetes management overview screen

DAVE™ patient overview

This screen displays a summary of all of the patient’s data relevant to their diabetes care, including scroll boxes displaying the relevant prescriptions, referrals, medical and family history.

Click image to enlarge

DAVE™ patient assessment

Data from this consultation can be entered using this screen – with all data being recorded back into the core GP system (such as Best Practice or Locum) where possible. Selecting check boxes from the left hand screen will note that selection in the ‘to-do’ box underneath the care item toolbar.

Click image to enlarge

Assessment screen
Privacy   |   Terms of use  |   Intellectual Property   |   powered by SiteSuite
The Pharmaceutical Alliance

The Pharmaceutical Alliance seeks views and guidance from a broad range of healthcare professionals. Where appropriate for these consultations, the Alliance provides remuneration specifically to cover their  time away from day-to-day responsibilities.  The Pharmaceutical Alliance has not provided any payment for comments expressed by people regarding the Alliance or its work. All views represent the opinions of the individual author and are independent of The Pharmaceutical Alliance.